Healthcare entity
Of the tracked stories, 2 of 2 also mention Boston Scientific, the most common co-covered peer. The 7-day window averages about 2 stories each week. The clearest coverage concentration is health-it: 1 of 2 stories, with the rest divided among 1 other category.
Last mentioned: Sep 2, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Of the tracked stories, 2 of 2 also mention Boston Scientific, the most common co-covered peer. The 7-day window averages about 2 stories each week. The clearest coverage concentration is health-it: 1 of 2 stories, with the rest divided among 1 other category. The tracked stories average 2.5 original sources each. West Pharmaceutical Services appears in 2 tracked Healthcare stories published from August 27, 2026 through September 2, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 6 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering West Pharmaceutical Services. Shared-story counts are live from our verified record — not editorial picks.
Public breach disclosure
Novocure publicly reported the cyberattack, disclosing that internal records of more than 1,400 U.S. patients were exposed.
Unauthorized access occurs
Novocure says unauthorized access to certain information systems occurred in mid-August 2026, exposing internal patient records.
Incident response activated
Novocure activated its cybersecurity response plan, implemented containment measures, and initiated an internal investigation.
Novocure disclosed a mid-August cyberattack that exposed internal records of more than 1,400 U.S. oncology patients, along with provider contact details and employee job titles. The company said treatment devices were not accessed and that it expects no material financial impact. For healthcare IT and compliance leaders, the incident is another compelling case study in breach response, data classification, and regulatory risk.
Source: CNA
A cybersecurity incident at Boston Scientific has disrupted order processing and shipping globally, threatening hospitals and surgical centers reliant on its devices. Analysts warn of a 600-700 bps Q3 revenue hit if recovery matches Stryker's three-week timeline. Health leaders must assess supply chain and patient care risks.
Source: CNA · Sahil Pandey
West Pharmaceutical Services is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
